identifier: Marketing Authorisation Number/5204201

subject: MedicinalProductDefinition: extension = Tablet and solvent for rectal suspension; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01002393-0520420010000; combinedPharmaceuticalDoseForm = Tablet and solvent for rectal suspension; indication = Leichte bis mittelschwere Colitis ulcerosa des Rectums sowie des Colon sigmoideum.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = budesonide,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,04. GASTROENTEROLOGICA,04.99. Varia

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 1993-06-18

holder: Organization Tillotts Pharma AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products

Generated Narrative: Organization #holder-Tillotts-Pharma-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01002393, LOC Identifier/100005174, GLN Identifier/7601001346451

name: Tillotts Pharma AG

Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products